Romazicon and Osteomyelitis - a phase IV clinical study of FDA data

Summary:

Osteomyelitis is reported as a side effect among people who take Romazicon (flumazenil), especially for people who are female, 50-59 old, also take Versed, and have Hypercalcaemia of malignancy.

The phase IV clinical study analyzes which people have Osteomyelitis when taking Romazicon. It is created by eHealthMe based on reports of 182 people who have side effects when taking Romazicon from the FDA, and is updated regularly.

What is Romazicon?

Romazicon has active ingredients of flumazenil. eHealthMe is studying from 182 Romazicon users. Check the latest studies of Romazicon.

What is Osteomyelitis?

Osteomyelitis (infection of bone) is found to be associated with 1,420 drugs and 1,330 conditions by eHealthMe. Check the latest studies of Osteomyelitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

182 people reported to have side effects when taking Romazicon.
Among them, 15 people (8.24%) have Osteomyelitis.

Among these 15 people:

What is the gender of people who have Osteomyelitis when taking Romazicon? *

female: 93.33 %
male: 6.67 %

What is the age of people who have Osteomyelitis when taking Romazicon? *

What are other drugs people take besides Romazicon? *

What are other side effects people have besides Osteomyelitis? *

Abdominal Pain: 15 people, 100.00%
Swallowing Difficulty: 15 people, 100.00%
Pain: 15 people, 100.00%
Osteonecrosis Of Jaw (death of bone of jaw): 15 people, 100.00%
Stress And Anxiety: 15 people, 100.00%
Dizziness: 15 people, 100.00%
Osteopenia (a condition where bone mineral density is lower than normal): 15 people, 100.00%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 15 people, 100.00%
Swelling: 14 people, 93.33%
Injury: 14 people, 93.33%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 12 people, 80.00%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 12 people, 80.00%
Pain: 5 people, 33.33%
Breast Cancer: 3 people, 20.00%
Urinary Tract Infection: 1 person, 6.67%
High Blood Cholesterol: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Romazicon and have Osteomyelitis?

- Check whether Osteomyelitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Romazicon:

Romazicon (182 reports)

Osteomyelitis treatments and more:

Osteomyelitis (34,172 reports)

Browse all side effects of Romazicon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteomyelitis:

Osteomyelitis (1,420 drugs)

Browse all the conditions that are associated with Osteomyelitis:

Osteomyelitis (1,330 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on flumazenil (the active ingredients of Romazicon) and Romazicon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.